Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, November 25, 2009, 3:16PM AEST - The Australian Stockmarket closes in 49 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
Crucell NV (CRXL)
8:00AM AEST:
21.56 USD
0.10 (0.46%)
MORE ON CRXL
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Crucell NV
(NasdaqNM:CRXL) Delayed quote data
Last Trade:
21.56 USD
Trade Time:
8:00AM AEST
Change:
0.10 (0.46%)
Prev Close:
21.66
Open:
21.86
Bid:
20.91
x 100
Ask:
22.13
x 100
1y Target Est:
24.79
Day's Range:
21.48 - 21.86
52wk Range:
12.40 - 25.53
Volume:
93,407
Avg Vol
(3m)
:
337,080
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add CRXL to Portfolio
Download Data
HEADLINES
Vaccines on horizon for AIDS, Alzheimer's, herpes
AP
(Wed, Nov 18)
Vaccines on horizon for AIDS, Alzheimer's, herpes
AP
(Wed, Nov 18)
Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
Marketwire
(Mon, Nov 16)
The Complete List of Dutch ADR Stocks
at Seeking Alpha
(Wed, Nov 11)
TapImmune Signs License Agreement With Crucell N.V.
GlobeNewswire
(Fri, Nov 6)
Crucell N.V. upgraded by UBS
Briefing.com
(Fri, Nov 6)
Johnson & Johnson to cut up to 8,200 jobs
at MarketWatch
(Wed, Nov 4)
Crucell 3Q profit falls 22 percent
AP
(Wed, Nov 4)
Crucell Earnings Presentation Call scheduled for 8:00 am ET today
CCBN
(Wed, Nov 4)
Q3 2009 Crucell Earnings Release - 01:45 am ET
CCBN
(Tue, Nov 3)
Calmune and Crucell Enter Exclusive Research Collaboration
Marketwire
(Tue, Nov 3)
More Headlines for CRXL...
ANALYST
EPS Est (next year)
(Dec-09)
:
0.21
EPS Est (in 2 years)
(Dec-10)
:
0.63
Avg Rec (current)*:
1.5
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
No business summary available for CRXL.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices